Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$819M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$783M |
| 3 |
Apple
AAPL
|
+$750M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$605M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$484M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.72B |
| 2 |
TransUnion
TRU
|
+$1.09B |
| 3 |
Amazon
AMZN
|
+$1.05B |
| 4 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$451M |
| 5 |
Wells Fargo
WFC
|
+$385M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.29% |
| 2 | Financials | 10.73% |
| 3 | Healthcare | 9.01% |
| 4 | Consumer Discretionary | 8.24% |
| 5 | Industrials | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5126
CALL
Invesco
IVZ
$13.4B
| $118K | ﹤0.01% |
3,700
-44,100
| -92% | -$1.52M |
|
5127
Spyre Therapeutics
SYRE
$8.3B
| $118K | ﹤0.01% |
+476
| New | +$86K |
|
5128
Aldeyra Therapeutics
ALDX
$91.7M
| $117K | ﹤0.01% |
+15,567
| New | +$118K |
|
|
EIGR
5129
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $116K | ﹤0.01% |
+394
| New | +$116K |
|
|
PCOM
5130
DELISTED
Points.com Inc. Common Shares
PCOM
| $116K | ﹤0.01% |
+11,904
| New | +$129K |
|
5131
Costamare
CMRE
$1.86B
| $115K | ﹤0.01% |
18,409
-31,249
| -63% | -$197K |
|
5132
Information Services Group
III
$203M
| $115K | ﹤0.01% |
27,467
-3,147
| -10% | -$13.2K |
|
|
AVID
5133
DELISTED
Avid Technology Inc
AVID
| $115K | ﹤0.01% |
25,287
+3,451
| +16% | +$17.5K |
|
|
ANTH
5134
CALL
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $115K | ﹤0.01% |
+360,000
| New | +$538K |
|
5135
CALL
Healthpeak Properties
DOC
$15.1B
| $114K | ﹤0.01% |
4,900
-207,600
| -98% | -$4.82M |
|
5136
XBiotech
XBIT
$67.7M
| $114K | ﹤0.01% |
21,271
-56,504
| -73% | -$260K |
|
|
ISEE
5137
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $114K | ﹤0.01% |
41,703
-125,164
| -75% | -$363K |
|
5138
PUT
Huntington Bancshares
HBAN
$34.8B
| $113K | ﹤0.01% |
7,500
-17,300
| -70% | -$272K |
|
5139
PUT
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.86B
| $113K | ﹤0.01% |
3,600
-6,400
| -64% | -$204K |
|
5140
Cartesian Therapeutics
RNAC
$229M
| $113K | ﹤0.01% |
370
-612
| -62% | -$174K |
|
|
VRAY
5141
DELISTED
ViewRay, Inc.
VRAY
| $113K | ﹤0.01% |
+17,583
| New | +$147K |
|
5142
CALL
Alaska Air
ALK
$5.56B
| $112K | ﹤0.01% |
1,800
-6,400
| -78% | -$425K |
|
5143
PUT
Golar LNG
GLNG
$4.96B
| $112K | ﹤0.01% |
4,100
-6,600
| -62% | -$186K |
|
|
PNNT
5144
Pennant Park Investment Corp
PNNT
$221M
| $112K | ﹤0.01% |
16,777
-142,682
| -89% | -$989K |
|
|
SEM
5145
PUT
DELISTED
Select Medical
SEM
| $112K | ﹤0.01% |
12,064
-7,981
| -40% | -$76K |
|
5146
PUT
J.M. Smucker
SJM
$12.7B
| $112K | ﹤0.01% |
900
-2,300
| -72% | -$287K |
|
|
SITO
5147
DELISTED
SITO MOBILE, LTD
SITO
| $112K | ﹤0.01% |
27,743
+17,488
| +171% | +$94.8K |
|
|
TOO
5148
DELISTED
Teekay Offshore Partners L.P.
TOO
| $112K | ﹤0.01% |
49,409
+6,600
| +15% | +$16.8K |
|
5149
Calix
CALX
$2.32B
| $111K | ﹤0.01% |
16,219
-29,146
| -64% | -$188K |
|
5150
CALL
Ovintiv
OVV
$17.1B
| $111K | ﹤0.01% |
2,020
-12,680
| -86% | -$752K |
|
Similar funds
Goldman Sachs's Q1 2018 Portfolio in Review
As of Q1 2018, Goldman Sachs held 6,750 positions worth $391B, down 6.5% from $418B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Goldman Sachs withdrew a net $24B in Q1 2018, closing 894 positions and reducing 2,785 holdings. Its most notable exit was TransUnion, an estimated $1.09B position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 10% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Goldman Sachs opened a new position in Americold worth $454M.
- Goldman Sachs's largest Q1 2018 buy was Americold: 23,769,508 shares worth $454M.
- Goldman Sachs added most to Microsoft in Q1 2018, an estimated $819M increase.
- Goldman Sachs's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.72B.
- Goldman Sachs fully exited TransUnion in Q1 2018, selling an estimated $1.09B.
- Goldman Sachs's ten largest holdings make up 14% of its $391B portfolio in Q1 2018.
- Goldman Sachs opened 453 new positions and closed 894 in Q1 2018.
- Goldman Sachs's portfolio value fell 6.5% quarter-over-quarter to $391B.
Based on Goldman Sachs's 13F filing for Q1 2018, filed 15 May 2018.